Clinical trial · Interventional
Post-Mastectomy Surveillance to Detect Recurrence in Breast Cancer Patients
Post-Mastectomy Surveillance to Detect Locally Recurrent Breast Cancer
NCT02688725CI-TRIAL-00040291unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Currently, there is no standard recommendation for using imaging studies to check patients for breast cancer recurrence who have been treated with mastectomy. The investigator proposes performing in-office ultrasound examinations of these patients to determine if this would be helpful in identifying an expected 5-7% of patients with breast cancer recurrences following mastectomy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| post mastectomy ultrasound | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Ultrasound
- description
- post mastectomy ultrasound
- interventionNames
- Device: post mastectomy ultrasound
Primary outcomes (1)
- measure
- To determine the number of breast cancer recurrences following mastectomy detected by surgeon-performed ultrasound.
- timeFrame
- 3 years
- description
- To determine the number of breast cancer recurrences following mastectomy detected by surgeon-performed ultrasound during a three year trial period.
Secondary outcomes (1)
- measure
- The sensitivity of surgeon performed breast ultrasound to detect breast cancer recurrence after mastectomy will be measured.
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * must be ≥ 18 years of age. * histologic diagnosis of invasive (ductal or lobular) or in situ (ductal) breast cancer (American Joint Committee on Cancer, 7th edition stage 0, I, II, III, or IV) -previously treated with mastectomy Exclusion Criteria: * pregnant or breast feeding. * cannot tolerate lying supine for breast ultrasound examination. * mastectomy for lobular carcinoma in situ, atypical ductal hyperplasia, or extensive microcalcifications in the absence of concurrent DCIS or invasive breast cancer
References
Publications (0)
Data not yet available
No reference posted for this study.